Iontophoretic Application of Acyclovir Gel to Treat Cold Sores
Public ClinicalTrials.gov record NCT00469300. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Placebo Controlled, Randomized, Double Blind, Subject Initiated Study of the Safety and Efficacy of the Electrokinetic Transdermal System (ETS) With Acyclovir Gel for the Episodic Treatment of Herpes Labialis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Currently approved drugs for the treatment of herpes labialis (cold sores) exhibit low levels of efficacy due to the limited ability of the drugs to penetrate the skin to the sites where the herpes virus is replicating. Iontophoresis uses electric current to enhance delivery of drugs through the skin. This trial is testing a new iontophoretic device with a new acyclovir gel to treat cold sores.
Study identification
- NCT ID
- NCT00469300
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 810 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2007 (Type not available)
- Primary completion
- Sep 2007 (Actual)
- Completion
- Oct 2007 (Actual)
- Last update posted
- Feb 4, 2008
2007
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Radiant Research Birmingham | Birmingham | Alabama | 35209 | — |
| Radiant Research Santa Rosa | Santa Rosa | California | 95405 | — |
| Radiant Research St. Petersburg | Pinellas Park | Florida | 33781 | — |
| Radiant Research Chicago | Chicago | Illinois | 60610 | — |
| Radiant Research Minneapolis | Edina | Minnesota | 55435 | — |
| Radiant Research St. Louis | St Louis | Missouri | 63141 | — |
| Rochester Clinical Research, Inc. | Rochester | New York | 14609 | — |
| Radiant Research Cincinnati | Cincinnati | Ohio | 45236 | — |
| Radiant Research Akron | Mogadore | Ohio | 44260 | — |
| OMEGA Medical Research | Warwick | Rhode Island | 02886 | — |
| Radiant Research Greer | Greer | South Carolina | 29651 | — |
| Radiant Research Dallas North | Dallas | Texas | 75231 | — |
| Radiant Research San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00469300, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 4, 2008 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00469300 live on ClinicalTrials.gov.